Skip to content
healthcare.dev

Rasagiline

NDC 47781-683, Rasagiline, tablet, from Alvogen, Inc..

Product NDC
47781-683
Status
Listed
Labeler
Alvogen, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201970
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47781-683 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE.5 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
47781-683-304778106833030 TABLET in 1 BOTTLE, PLASTIC (47781-683-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a62a9946-755f-47d0-afe6-edc8f7d641fe
  • NADAC price for package 47781068330

    GET /v1/drugs/nadac/47781068330

Use it

Look up 47781-683 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47781-683 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47781-683. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.